We use cookies to help provide you with the best possible online experience. Learn more

Press releases

Provision CARES Proton Therapy Center in Knoxville, Tennessee, US, treats first patients using RayStation and the new ProNova SC360 Proton System

Provision Healthcare, an industry- leading innovator in comprehensive, collaborative cancer solutions, has treated its first patients using RayStation in combination with Provision’s newly developed ProNova SC360 proton therapy system.

This milestone establishes a new standard of excellence combined with the most advanced technology available in proton therapy and treatment planning. The procedures were executed successfully, and the RayStation plan performed seamlessly with the ProNova control system.

In 2014, Provision became the first center in the world to use RayStation for clinical proton treatments.  The center provides advanced cancer treatment to patients locally, regionally and internationally. The Provision network has continued to push the boundaries of radiation therapy, when adding the ProNova SC360 proton system, and treating the first patient in February 2018. It now offers the latest in treatment technology, personalized medical practice and an innovative, integrative approach to comprehensive cancer care.

Niek Schreuder, VP and Chief Medical Physicist, for Provision Healthcare, says: “We have used RayStation clinically for years, and we have been collaborating with RaySearch since the beginning of the development of the SC360. We are delighted that things have gone so well, and as we open new centers throughout the world, we expect to implement RayStation, RayCare* and the SC360 system together to assure seamless interoperability and dynamic workflows.”

Johan Löf, CEO of RaySearch, says: “We are very pleased to support the Provision CARES Proton Therapy Network in achieving this treatment milestone with a state-of-the-art proton therapy solution. RayStation’s advanced capabilities are an excellent match for the center’s aims of increasing treatment precision and clinical efficiency. Together we are taking proton therapy forward for the benefit of cancer patients.”

About Provision CARES Proton Therapy Network  

The CARES Cancer Network is focused on providing the most comprehensive and advanced treatment options for patients. This network extends across the world and promotes collaborative care and research that benefits the patient and the larger fight against cancer. Provision CARES Proton Therapy Center in Knoxville is the first cancer treatment center of its kind in Tennessee. The center aims to provide personalized, comprehensive patient care with leading-edge technology, offering one of the most advanced non-invasive cancer treatments in the world.

About RayStation

RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.

To learn more about RaySearch, go to: www.raysearchlabs.com 

* Subject to regulatory clearance in some markets.

For further information, please contact:

Johan Löf, President and CEO, RaySearch Laboratories AB (publ)

Telephone: +46 (0)8-510 530 00